| |
ROCU01(A in EP)
Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate, (2β,3α,5α,16β,17β)-
[119302-24-8 ] |
|
ROCU02(B in EP)
Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-3,17-bis(acetyloxy)-2-(4-morpholinyl)androstan-16-yl]-1-(2-propen-1-yl)-
[745754-38-5 ] |
|
ROCU03(C in EP)
Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-3,17-dihydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-
[738548-78-2 ] |
|
ROCU04(D in EP)
Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-3-(acetyloxy)-17-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propen-1-yl)-
[942983-82-6 ] |
|
ROCU05(E in EP)
Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-17-(acetyloxy)-3-hydroxy-2-(1-pyrrolidinyl)androstan-16-yl]-1-(2-propen-1-yl)-
[942983-83-7 ] |
|
ROCU06(F in EP)
Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-3,17-bis(acetyloxy)-2-(1-pyrrolidinyl)androstan-16-yl]-1-(2-propen-1-yl)-
[942983-84-8 ] |
|
ROCU07(G in EP)
Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, (2β,3α,5α,16β,17β)-
[119302-20-4 ] |
|
ROCU08(H in EP)
Pyrrolidinium, 1-[(5α,16β,17β)-17-(acetyloxy)-2-(4-morpholinyl)-3-oxoandrost-1-en-16-yl]-1-(2-propen-1-yl)-
[942983-85-9 ] |
|
It will be provided for research purpose use only, if the chemical listed here is of potential infringing with the intellectual property rights of any other party in certain areas.
|
|
